Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NOX-6-18 (GPR132-B-160) is a highly potent and selective GPR132 antagonist with insulinotropic activity that modulates macrophage reprogramming in pancreatic islets and reduces weight gain.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 68.00 | |
5 mg | In stock | $ 163.00 | |
10 mg | In stock | $ 263.00 | |
25 mg | In stock | $ 529.00 | |
50 mg | In stock | $ 853.00 | |
100 mg | In stock | $ 1,360.00 |
Description | NOX-6-18 (GPR132-B-160) is a highly potent and selective GPR132 antagonist with insulinotropic activity that modulates macrophage reprogramming in pancreatic islets and reduces weight gain. |
Targets&IC50 | GPR132:0.075 μM(EC50) |
Synonyms | GPR132 antagonist 1, GPR132-B-160 |
Molecular Weight | 359.4 |
Formula | C18H17NO5S |
CAS No. | 898211-21-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (222.59 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NOX-6-18 898211-21-7 Endocrinology/Hormones GPCR/G Protein GPR GPR132 antagonist 1 NOX618 GPR132-B-160 inhibitor inhibit